15.1 Fluid Requirements, Dehydration Assessment & Maintenance Therapy

Board Certified Pediatric Pharmacy Specialist BCPPS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pediatric Patient Characteristics — Growth, Anthropometrics & Perinatal Exposure

1.1 Normal Growth, Development & Growth-Chart Interpretation 1.2 Anthropometrics: Body Surface Area, Dosing Weights & Maximum-Dose Caps 1.3 Medication Use in Pregnancy and Lactation

2 Chapter 2: Developmental Pharmacokinetics & Neonatal Principles

2.1 Developmental PK: Absorption, Distribution & Body Water Dynamics 2.2 Hepatic Metabolism & CYP/UGT Isoenzyme Maturation 2.3 Renal Function Maturation & Glomerular Filtration Development

3 Chapter 3: Neonatal Critical Care & Prematurity Complications

3.1 Neonatal Sepsis & Meningitis (Early-Onset vs Late-Onset Sepsis) 3.2 Respiratory Distress Syndrome, Surfactant & Bronchopulmonary Dysplasia 3.3 Patent Ductus Arteriosus, Apnea of Prematurity & Necrotizing Enterocolitis

4 Chapter 4: Pediatric Infectious Diseases — Respiratory & ENT Infections

4.1 Acute Otitis Media, Sinusitis & Pharyngitis 4.2 Pediatric Community-Acquired Pneumonia & Parapneumonic Effusion 4.3 Bronchiolitis, RSV Prevention (Nirsevimab, Clesrovimab, Palivizumab) & Viral Lower Respiratory Infections

5 Chapter 5: Pediatric Infectious Diseases — Systemic, Bone & CNS Infections

5.1 Pediatric Meningitis, Encephalitis & Brain Abscess 5.2 Skin, Soft Tissue, Osteomyelitis & Septic Arthritis 5.3 Pediatric Sepsis, Febrile Neutropenia & Central Line-Associated Bloodstream Infections

6 Chapter 6: Pediatric Pulmonary Medicine — Asthma & Status Asthmaticus

6.1 Chronic Pediatric Asthma Assessment & Stepwise Outpatient Pharmacotherapy 6.2 Status Asthmaticus & Acute Exacerbation Pharmacotherapy in ED/PICU 6.3 Aerosol Drug Delivery, Spacers & Specialized Inhalation Devices

7 Chapter 7: Cystic Fibrosis & Chronic Pediatric Respiratory Disorders

7.1 Pathophysiology, Diagnosis & Airway Clearance in Cystic Fibrosis 7.2 CFTR Modulator Therapies & Monitoring 7.3 CF Pulmonary Exacerbations, Chronic Infection Management & Comorbidities

8 Chapter 8: Pediatric Cardiology & Hemodynamics

8.1 Congenital Heart Defects & Ductal-Dependent Lesions 8.2 Pediatric Heart Failure & Cardiomyopathies 8.3 Pediatric Arrhythmias & Syncope Management

9 Chapter 9: Pediatric Resuscitation, Shock & Critical Care Support

9.1 PALS Resuscitation Algorithms & Cardiac Arrest Pharmacotherapy 9.2 Pediatric Shock States & Vasoactive / Inotropic Selection 9.3 Extracorporeal Membrane Oxygenation (ECMO) & Critical Care PK

10 Chapter 10: Pediatric Neurology & Psychiatric Disorders

10.1 Neonatal Seizures & Pediatric Status Epilepticus 10.2 Pediatric Epilepsy Syndromes & Maintenance Anticonvulsants 10.3 Attention-Deficit/Hyperactivity Disorder (ADHD) & Pediatric Mood Disorders

11 Chapter 11: Pediatric Endocrinology & Metabolic Disorders

11.1 Pediatric Type 1 Diabetes Mellitus Management & Insulin Technologies 11.2 Diabetic Ketoacidosis (DKA) Protocols & Cerebral Edema Prevention 11.3 Growth Hormone, Pubertal Disorders & Congenital Adrenal Hyperplasia

12 Chapter 12: Pediatric Hematology, Oncology & Supportive Care

12.1 Sickle Cell Disease: Vaso-occlusive Crises & Disease-Modifying Therapies 12.2 Pediatric Acute Lymphoblastic Leukemia (ALL) & Chemotherapy Toxicities 12.3 Oncologic Emergencies: Tumor Lysis Syndrome & Supportive Care

13 Chapter 13: Pediatric Medication Safety & Error Prevention

13.1 High-Alert Pediatric Medications & Ten-Fold Dosing Calculation Traps 13.2 Smart Infusion Pumps & Dose Error Reduction Systems (DERS) 13.3 Medication Reconciliation & Pediatric Care Transitions

14 Chapter 14: Pediatric Compounding & Formulation Technology

14.1 Non-Sterile Compounding (USP <795>) & Liquid Formulations 14.2 Sterile Compounding (USP <797>) & Micro-Dosing Considerations 14.3 Hazardous Drug Handling (USP <800>) & Excipient Toxicities

15 Chapter 15: Fluids, Electrolytes & Clinical Nutrition Support

15.1 Fluid Requirements, Dehydration Assessment & Maintenance Therapy 15.2 Electrolyte Disturbances: Sodium, Potassium & Calcium Management 15.3 Pediatric & Neonatal Parenteral Nutrition (PN) Formulation

16 Chapter 16: Pediatric Pain Management, Sedation & Delirium

16.1 Age-Specific Pain Assessment Tools & Analgesic Selection 16.2 Procedural Sedation & Rapid Sequence Intubation in Children 16.3 PICU Delirium, Iatrogenic Withdrawal & Weaning Strategies

17 Chapter 17: Biostatistics & Study Design in Pediatric Research

17.1 Observational vs Experimental Pediatric Study Designs 17.2 Biostatistical Testing, Power & Sample Size in Small Pediatric Cohorts 17.3 Diagnostic Testing, Sensitivity, Specificity & Predictive Values

18 Chapter 18: Pediatric Evidence Appraisal, Regulatory Framework & Ethics

18.1 Pediatric Drug Legislation: BPCA, PREA & Labeling Nuances 18.2 Institutional Review Boards (IRB), Assent & Informed Consent in Minors 18.3 Evaluating Clinical Practice Guidelines & Formulating Off-Label Recommendations

19 Chapter 19: Pediatric Education, Health Literacy & Communication

19.1 Caregiver Health Literacy & Pediatric Medication Adherence 19.2 Interprofessional Education & Clinical Teaching Strategies 19.3 Developing Age-Appropriate Patient Educational Materials

20 Chapter 20: Pediatric Immunizations & Public Health Advocacy

20.1 ACIP Pediatric Immunization Schedule: Routine Childhood Vaccines 20.2 Adolescent Immunizations, Vaccine Hesitancy & Catch-Up Schedules 20.3 Pediatric Public Health Disparities & Special Population Advocacy

21 Chapter 21: Pediatric Practice Management — Laboratory Stewardship, Pharmacoeconomics & Informatics

21.1 Pediatric Laboratory Practices: Blood Conservation, Sampling Timing & Age-Specific Reference Intervals 21.2 Pharmacoeconomics, Formulary Management & Cost-Containment in Pediatrics 21.3 Clinical Informatics, CPOE Decision Support & Drug Shortage Management

15.1 Fluid Requirements, Dehydration Assessment & Maintenance Therapy

Key Takeaways Explain This Topic AI

The Holliday-Segar method calculates 24-hour maintenance fluid requirements: 100 mL/kg for the first 10 kg, 50 mL/kg for kilograms 11–20, and 20 mL/kg for each kilogram above 20 kg, matching the 4-2-1 hourly infusion rule (4 mL/kg/h for 1–10 kg, 2 mL/kg/h for 11–20 kg, and 1 mL/kg/h for >20 kg).

Neonatal fluid requirements advance dynamically from Day 1 (60–80 mL/kg/day) by 10–20 mL/kg/day to reach full maintenance of 120–150 mL/kg/day by days 5–7, reflecting physiologic contraction of extracellular water and postnatal diuresis.

Dehydration severity is categorized by percent weight loss: mild (3–5%), moderate (6–9%), and severe (≥10% in infants, ≥6–9% in older children), with severe dehydration manifested by sunken fontanelles, prolonged capillary refill (>3 seconds), skin tenting, lethargy, and hypotension.

Emergent intravascular resuscitation requires rapid isotonic crystalloid boluses of 20 mL/kg (0.9% sodium chloride or Plasma-Lyte) administered over 15–30 minutes, repeatable up to 40–60 mL/kg in the first hour before transitioning to maintenance plus deficit replacement.

Oral Rehydration Therapy (ORT) utilizing WHO/CDC reduced-osmolarity solutions (245 mOsm/L, 75 mEq/L Na) dosed at 50–100 mL/kg over 4 hours is superior to intravenous hydration for mild-to-moderate gastroenteritis, resulting in fewer hospitalizations and systemic complications.

Last updated: September 2026

15.1 Fluid Requirements, Dehydration Assessment & Maintenance Therapy

Fluid and electrolyte management is a cornerstone of pediatric clinical pharmacy practice. Because infants and young children possess a substantially higher ratio of total body water to body weight, higher metabolic rates, and immature renal concentrating capacity compared to adults, they are exceptionally vulnerable to rapid dehydration, electrolyte disarray, and iatrogenic fluid overload. Pharmacists must master the precise calculation of baseline maintenance fluid requirements, understand neonatal fluid dynamics, accurately grade dehydration severity, and design both emergent resuscitation and oral rehydration regimens.

Maintenance Fluid Requirements: The Holliday-Segar Method

Introduced in 1957 by Malcolm Holliday and William Segar, the Holliday-Segar method calculates daily fluid requirements based on caloric expenditure under basal conditions. In pediatric patients, energy expenditure closely correlates with water loss: for every 100 kilocalories (kcal) metabolized, approximately 100 mL of water is required to balance insensible losses (skin and lungs, ~45 mL/100 kcal), urinary losses (~50 mL/100 kcal), and stool losses (~5 mL/100 kcal). Body Weight (kg) 24-Hour Holliday-Segar Fluid Requirement 0 – 10 kg 100 mL/kg/day 11 – 20 kg 1 , 000 mL + 50 mL/kg for each kg between 11 and 20 kg > 20 kg 1 , 500 mL + 20 mL/kg for each kg above 20 kg \begin{array}{l|l}

\hline
\textbf{Body Weight (kg)} & \textbf{24-Hour Holliday-Segar Fluid Requirement} \\
\hline
\mathbf{0\text{--}10\text{ kg}} & 100\text{ mL/kg/day} \\
\mathbf{11\text{--}20\text{ kg}} & 1,000\text{ mL} + 50\text{ mL/kg for each kg between 11 and 20 kg} \\
\mathbf{> 20\text{ kg}} & 1,500\text{ mL} + 20\text{ mL/kg for each kg above 20 kg} \\
\hline

\end{array} Body Weight (kg) 0 – 10 kg 11 – 20 kg > 20 kg 24-Hour Holliday-Segar Fluid Requirement 100 mL/kg/day 1 , 000 mL + 50 mL/kg for each kg between 11 and 20 kg 1 , 500 mL + 20 mL/kg for each kg above 20 kg

The 4-2-1 Hourly Infusion Rule

To convert the 24-hour Holliday-Segar volume into an hourly continuous intravenous infusion rate, clinicians utilize the 4-2-1 rule :

First 10 kg (1–10 kg): 4 mL/kg/hour 4\text{ mL/kg/hour} 4 mL/kg/hour

Second 10 kg (11–20 kg): Add 2 mL/kg/hour 2\text{ mL/kg/hour} 2 mL/kg/hour for each kilogram between 11 and 20 kg (base rate: 40 mL/h + [ 2 × ( weight − 10 ) ] 40\text{ mL/h} + [2 \times (\text{weight} - 10)] 40 mL/h + [ 2 × ( weight − 10 )] ).

Each kg above 20 kg (> 20 kg): Add 1 mL/kg/hour 1\text{ mL/kg/hour} 1 mL/kg/hour for each kilogram above 20 kg (base rate: 60 mL/h + [ 1 × ( weight − 20 ) ] 60\text{ mL/h} + [1 \times (\text{weight} - 20)] 60 mL/h + [ 1 × ( weight − 20 )] ).

Standard Adult Maximum: Typically capped at 100 to 120 mL/hour 100\text{ to } 120\text{ mL/hour} 100 to 120 mL/hour ( 2 , 400 – 2 , 880 mL/day 2,400\text{--}2,880\text{ mL/day} 2 , 400 – 2 , 880 mL/day ) unless replacing documented abnormal losses. Clinical Calculation Examples:

1. Infant weighing 8.0 kg:

24-Hour: 8 kg × 100 mL/kg = 800 mL/day
Hourly Rate: 8 kg × 4 mL/kg/h = 32 mL/h (32 mL/h × 24 h = 768 mL ~ 800 mL)

2. Child weighing 16.0 kg:

24-Hour: 1,000 mL + (6 kg × 50 mL/kg) = 1,000 + 300 = 1,300 mL/day
Hourly Rate: 40 mL/h + (6 kg × 2 mL/kg/h) = 52 mL/h

3. Child weighing 28.0 kg:

24-Hour: 1,500 mL + (8 kg × 20 mL/kg) = 1,500 + 160 = 1,660 mL/day
Hourly Rate: 60 mL/h + (8 kg × 1 mL/kg/h) = 68 mL/h
Postnatal Fluid Progression in Neonates

The Holliday-Segar method is designed for infants and children beyond the immediate neonatal transition period. Full-term and preterm neonates undergo a unique physiologic contraction of their expanded extracellular fluid (ECF) volume during the first week of life, resulting in expected physiologic weight loss:

Full-term neonates: Lose 5% to 10% of birth weight over days 1 to 5, regaining birth weight by 10 to 14 days of life.

Preterm / ELBW neonates (< 1,000 g): Lose 10% to 15% of birth weight over days 1 to 7.

Providing excessive fluids during this initial phase suppresses physiologic diuresis and is strongly associated with patent ductus arteriosus (PDA), necrotizing enterocolitis (NEC), bronchopulmonary dysplasia (BPD), and intraventricular hemorrhage (IVH).

Standard Neonatal Fluid Advancement Protocol

Postnatal Age Full-Term Target Volume Preterm (< 32 weeks) Target Volume Clinical Milestones & Additives
Day 1 of life 60–80 mL/kg/day 80–100 mL/kg/day Initiate D10W (± amino acids); no electrolytes
Day 2 of life 80–100 mL/kg/day 100–120 mL/kg/day Advance fluid as urine output confirms diuresis
Day 3 of life 100–120 mL/kg/day 120–140 mL/kg/day Add sodium and potassium once diuresis is established
Day 4 of life 120–140 mL/kg/day 130–150 mL/kg/day Monitor electrolytes, weight change, and serum sodium

Day 5–7 (Full Maintenance) 140–160 mL/kg/day 140–180 mL/kg/day Extremely preterm infants may require up to 180 mL/kg/day due to high TEWL

Note

Transepidermal Water Loss (TEWL): Extremely low birth weight (ELBW, < 1,000 g) and extremely preterm (< 28 weeks) infants have an unkeratinized stratum corneum and a very high body surface area-to-weight ratio, leading to massive insensible transcutaneous evaporative water losses (up to 100–150 mL/kg/day). Humidified incubators (70–85% ambient humidity) and plastic occlusive wraps are essential non-pharmacologic interventions to blunt TEWL and prevent severe hypernatremic dehydration.

Maintenance Fluid Composition: Preventing Hospital-Acquired Hyponatremia

Historically, pediatric maintenance intravenous fluids consisted of hypotonic crystalloids (such as 0.2 % NaCl 0.2\%\text{ NaCl} 0.2% NaCl [quarter-normal saline] or 0.45 % NaCl 0.45\%\text{ NaCl} 0.45% NaCl [half-normal saline] in 5 % dextrose 5\%\text{ dextrose} 5% dextrose ). However, extensive clinical trials demonstrated that hospitalized pediatric patients frequently experience non-osmotic secretion of antidiuretic hormone (arginine vasopressin [AVP]) stimulated by pain, nausea, fever, stress, volume depletion, and surgical procedures.

Infusing hypotonic fluids in the presence of elevated AVP impairs free water excretion by renal collecting ducts, causing rapid water retention and iatrogenic hospital-acquired hyponatremia , which has resulted in fatal cerebral herniation and seizures.

American Academy of Pediatrics (AAP) Clinical Practice Guideline

Important

The AAP guidelines strongly mandate that isotonic intravenous fluids (such as 0.9 % Sodium Chloride 0.9\%\text{ Sodium Chloride} 0.9% Sodium Chloride or balanced crystalloids [Plasma-Lyte or Lactated Ringer's] with 5 % Dextrose 5\%\text{ Dextrose} 5% Dextrose ) must be used as the standard maintenance solution for hospitalized pediatric patients aged 28 days to 18 years .

Dextrose: 5 % Dextrose 5\%\text{ Dextrose} 5% Dextrose ( 50 g/L 50\text{ g/L} 50 g/L ) provides basal calories ( 170 kcal/L 170\text{ kcal/L} 170 kcal/L ) to suppress starvation ketoacidosis, prevent hypoglycemia, and reduce protein catabolism.

Potassium: 20 mEq/L Potassium Chloride (KCl) 20\text{ mEq/L Potassium Chloride (KCl)} 20 mEq/L Potassium Chloride (KCl) is added once renal function is verified.

Crucial Safety Rule: Never add potassium to maintenance intravenous fluids until the patient has successfully voided (documented urine output ≥ 1 mL/kg/hour \ge 1\text{ mL/kg/hour} ≥ 1 mL/kg/hour ). Administering potassium to an anuric patient with undiagnosed acute kidney injury can precipitate fatal hyperkalemic ventricular arrhythmias.

Dehydration Assessment & Clinical Staging

Dehydration in pediatric patients is predominantly caused by acute gastroenteritis (viral pathogens like rotavirus and norovirus), vomiting, diabetic ketoacidosis, burns, and heat-related illness. Because pediatric extracellular fluid volume turns over rapidly, volume depletion can escalate from mild thirst to decompensated hypovolemic shock within hours.

Calculating Percent Body Weight Loss

The gold standard for quantifying dehydration severity is the percentage of acute body weight loss: Percent Dehydration (%) = Pre-Illness Weight (kg) − Current Weight (kg) Pre-Illness Weight (kg) × 100 % \text{Percent Dehydration (\%)} = \frac{\text{Pre-Illness Weight (kg)} - \text{Current Weight (kg)}}{\text{Pre-Illness Weight (kg)}} \times 100\% Percent Dehydration (%) = Pre-Illness Weight (kg) Pre-Illness Weight (kg) − Current Weight (kg) × 100% Total Fluid Deficit (mL) = % Dehydration × Pre-Illness Weight (kg) × 10 \text{Total Fluid Deficit (mL)} = \% \text{ Dehydration} \times \text{Pre-Illness Weight (kg)} \times 10 Total Fluid Deficit (mL) = % Dehydration × Pre-Illness Weight (kg) × 10

(Note: 1 % weight loss = 10 mL/kg fluid deficit 1\%\text{ weight loss} = 10\text{ mL/kg fluid deficit} 1% weight loss = 10 mL/kg fluid deficit . For example, a 7% deficit in a 10-kg child equals 7 × 10 × 10 = 700 mL 7 \times 10 \times 10 = 700\text{ mL} 7 × 10 × 10 = 700 mL .)

When pre-illness weights are unavailable, clinicians use validated clinical grading criteria:

Clinical Parameter Mild Dehydration (3–5% Infant, 3–4% Child) Moderate Dehydration (6–9% Infant, 5–7% Child) Severe Dehydration (≥ 10% Infant, ≥ 8–9% Child)

General Appearance Alert, active, thirsty Irritable, lethargic, thirsty Stuporous, obtunded, comatose, limp
Heart Rate Normal Tachycardia Severe tachycardia; bradycardia in terminal shock
Blood Pressure Normal Normal (compensated) Hypotension (decompensated shock; late finding)
Peripheral Pulses Full, normal Weak, thready Absent or barely palpable

Capillary Refill < 2 seconds < 2\text{ seconds} < 2 seconds Prolonged ( 2 – 3 seconds 2\text{--}3\text{ seconds} 2 – 3 seconds ) Markedly prolonged ( > 3 – 4 seconds > 3\text{--}4\text{ seconds} > 3 – 4 seconds ); cool, mottled limbs

Mucous Membranes Slightly dry Dry, tacky oral mucosa Parched, cracked lips and tongue
Tears Normal Decreased Completely absent
Anterior Fontanelle Flat / normal Sunken Deeply sunken
Eyes Normal Mildly sunken Deeply sunken orbits; dark circles

Skin Turgor Instant recoil Delayed recoil ( < 2 seconds < 2\text{ seconds} < 2 seconds ) Skin tenting (prolonged recoil > 2 seconds > 2\text{ seconds} > 2 seconds )

Urine Output Normal to slightly decreased Oliguria ( < 1 mL/kg/h < 1\text{ mL/kg/h} < 1 mL/kg/h ) Anuria / severe oliguria ( < 0.5 mL/kg/h < 0.5\text{ mL/kg/h} < 0.5 mL/kg/h )

The Clinical Dehydration Scale (CDS)

The Clinical Dehydration Scale provides a rapid, validated scoring framework (0 to 8 points) in children aged 1 to 36 months presenting with gastroenteritis:

General Appearance: Normal = 0; Thirsty/restless = 1; Lethargic/floppy = 2
Eyes: Normal = 0; Slightly sunken = 1; Markedly sunken = 2
Mucous Membranes: Moist = 0; Tacky/sticky = 1; Completely dry = 2
Tears: Present = 0; Decreased = 1; Absent = 2

Interpretation: Score 0 = No dehydration; Score 1–4 = Some (mild-to-moderate) dehydration; Score 5–8 = Moderate-to-severe dehydration.

Intravenous Resuscitation & Rehydration Regimens Clinical Management Algorithm for Pediatric Dehydration:

[Evaluate Hemodynamic Stability & Dehydration %]
│
┌────────────────────────┴────────────────────────┐
▼ ▼
[Severe Dehydration / Shock] [Mild-to-Moderate (3-9%)]
(Cap refill >3s, hypotension, (Hemodynamically stable,
sunken fontanelle, lethargy) tolerating oral sips)
│ │
▼ ▼
[EMERGENCY IV RESUSCITATION] [ORAL REHYDRATION (ORT)]
20 mL/kg Isotonic Crystalloid • Reduced-osmolarity ORS
(0.9% NaCl or Plasmalyte) (245 mOsm/L; 75 mEq/L Na)
over 15-30 minutes • 50-100 mL/kg over 4 hours
Repeat up to 40-60 mL/kg if needed • Replace ongoing losses
│ • Single-dose Ondansetron
▼ if persistent vomiting
[MAINTENANCE + DEFICIT REPLACEMENT]
Subtract boluses from total deficit
Replace 50% deficit over first 8 hours
Replace remaining 50% over next 16 hours
Add continuous maintenance fluids (D5 0.9% NaCl + 20 mEq/L KCl)
Phase 1: Emergent Intravascular Resuscitation

When a child exhibits severe dehydration, signs of hypoperfusion, or decompensated hypovolemic shock, restoring intravascular circulating volume takes precedence over all other calculations.

Fluid Choice: Isotonic crystalloid exclusively— 0.9 % Sodium Chloride 0.9\%\text{ Sodium Chloride} 0.9% Sodium Chloride or balanced crystalloids ( Plasma-Lyte A or Lactated Ringer's ).

Contraindications in Bolus: Hypotonic crystalloids ( 0.45 % NaCl 0.45\%\text{ NaCl} 0.45% NaCl , 0.2 % NaCl 0.2\%\text{ NaCl} 0.2% NaCl ) and dextrose-containing solutions ( D 5 W D5W D 5 W , D 10 W D10W D 10 W ) are strictly contraindicated for rapid resuscitation boluses; they trigger rapid intracellular shifts, cerebral edema, and osmotic diuresis.

Initial Bolus Dose: 20 mL/kg 20\text{ mL/kg} 20 mL/kg IV push over 15 to 30 minutes (run over 5–10 minutes in catastrophic uncompensated shock).

Reassessment: After each bolus, evaluate heart rate, pulse volume, capillary refill, mental status, and palpate the liver edge and auscultate the lungs to detect early signs of fluid overload (hepatomegaly, crackles).

Repetition: The 20 mL/kg 20\text{ mL/kg} 20 mL/kg bolus may be repeated up to 40 to 60 mL/kg 40\text{ to } 60\text{ mL/kg} 40 to 60 mL/kg in the first hour if shock persists. If shock remains refractory after 60 mL/kg 60\text{ mL/kg} 60 mL/kg , initiate vasoactive inotropic support and investigate septic, cardiogenic, or hemorrhagic etiologies.

Phase 2: Deficit Replacement and Maintenance Therapy

Once intravascular perfusion is stabilized, calculate the remaining fluid deficit and formulate a 24- to 48-hour rehydration schedule:

Calculate Total Deficit (mL): % Dehydration × Weight (kg) × 10 \%\text{ Dehydration} \times \text{Weight (kg)} \times 10 % Dehydration × Weight (kg) × 10 .

Subtract Resuscitation Boluses: Subtract any isotonic crystalloid boluses administered during initial resuscitation from the calculated total fluid deficit.

Isonatremic Dehydration Replacement Schedule:

First 8 Hours: Administer 50 % 50\% 50% of the remaining fluid deficit plus 1 / 3 1/3 1/3 of the 24-hour maintenance fluid volume .

Subsequent 16 Hours: Administer the remaining 50 % 50\% 50% of the fluid deficit plus the remaining 2 / 3 2/3 2/3 of the 24-hour maintenance fluid volume .

Fluid Solution: Typically D 5 % with 0.9 % NaCl D5\%\text{ with } 0.9\%\text{ NaCl} D 5% with 0.9% NaCl (or 0.45 % NaCl 0.45\%\text{ NaCl} 0.45% NaCl ) + 20 mEq/L KCl + 20\text{ mEq/L KCl} + 20 mEq/L KCl (added once urination is verified).

Oral Rehydration Therapy (ORT)

Extensive international guidelines from the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and American Academy of Pediatrics (AAP) establish Oral Rehydration Therapy (ORT) as the first-line treatment for mild-to-moderate dehydration secondary to acute gastroenteritis.

Superiority of ORT Over Intravenous Hydration

Systematic reviews and Cochrane meta-analyses demonstrate that ORT is clinically superior or equal to IV rehydration in uncomplicated gastroenteritis:

Lower Failure Rate: Over 95 % 95\% 95% of children with mild-to-moderate dehydration are successfully rehydrated with ORT alone.

Fewer Complications: Eliminates risks of intravenous catheter infections, phlebitis, fluid extravasation, and iatrogenic hypervolemia or hyponatremia.

Shorter Hospital Stays: Reduces emergency department length of stay and hospital admission rates by > 50 % > 50\% > 50% .

Accelerated Mucosal Recovery: Intraluminal nutrients stimulate enterocyte repair and brush border enzyme regeneration.

Physiology: Sodium-Glucose Co-Transport

ORT exploits the intact sodium-glucose co-transporter-1 (SGLT-1) located on the brush border membrane of intestinal enterocytes. Even during severe viral enteritis (rotavirus) or toxin-mediated secretory diarrhea (Vibrio cholerae, enterotoxigenic E. coli) where active secretory pathways are stimulated, SGLT-1 remains fully functional. SGLT-1 transports one molecule of glucose together with two sodium ions from the intestinal lumen into the enterocyte cytoplasm. This creates an osmotic intracellular gradient that drives massive passive absorption of water through paracellular and transcellular channels.

Reduced-Osmolarity ORS Formulation

In 2002, the WHO and UNICEF revised the standard ORS formula from the original high-osmolarity formulation (311 mOsm/L) to the current reduced-osmolarity ORS (245 mOsm/L) , which significantly reduces stool output, vomiting frequency, and the need for unscheduled IV therapy:

Component WHO/UNICEF Reduced-Osmolarity ORS Commercial Solution (e.g., Pedialyte) Inappropriate Clear Liquids (Apple Juice / Soda / Sports Drinks)

Osmolarity 245 mOsm/L 245\text{ mOsm/L} 245 mOsm/L ∼ 250 mOsm/L \sim 250\text{ mOsm/L} ∼ 250 mOsm/L 350 – 700 + mOsm/L 350\text{--}700+\text{ mOsm/L} 350 – 700 + mOsm/L (Hyperosmolar)

Sodium 75 mEq/L 75\text{ mEq/L} 75 mEq/L 45 mEq/L 45\text{ mEq/L} 45 mEq/L 2 – 20 mEq/L 2\text{--}20\text{ mEq/L} 2 – 20 mEq/L (Profoundly low)

Glucose 75 mmol/L 75\text{ mmol/L} 75 mmol/L ( 13.5 g/L 13.5\text{ g/L} 13.5 g/L ) 140 mmol/L 140\text{ mmol/L} 140 mmol/L ( 25 g/L 25\text{ g/L} 25 g/L ) 300 – 700 mmol/L 300\text{--}700\text{ mmol/L} 300 – 700 mmol/L (Excessive carbohydrate)

Potassium 20 mEq/L 20\text{ mEq/L} 20 mEq/L 20 mEq/L 20\text{ mEq/L} 20 mEq/L 0.1 – 5 mEq/L 0.1\text{--}5\text{ mEq/L} 0.1 – 5 mEq/L

Citrate / Base 10 mmol/L 10\text{ mmol/L} 10 mmol/L 30 mEq/L 30\text{ mEq/L} 30 mEq/L Nil

Warning

Inappropriate Clear Fluids: Feeding children apple juice, cola, ginger ale, or sports drinks (e.g., Gatorade) during acute gastroenteritis is dangerous. Their high sugar content and hyperosmolality pull water into the intestinal lumen via osmosis, exacerbating secretory diarrhea. Concurrently, their negligible sodium content triggers severe dilutional hyponatremia and seizures.

Clinical ORT Protocol

Rehydration Phase (0–4 Hours):

Mild Dehydration: Administer 50 mL/kg 50\text{ mL/kg} 50 mL/kg of reduced-osmolarity ORS over 4 hours.

Moderate Dehydration: Administer 100 mL/kg 100\text{ mL/kg} 100 mL/kg of reduced-osmolarity ORS over 4 hours.

Technique: Administer small, frequent aliquots— 5 to 10 mL 5\text{ to } 10\text{ mL} 5 to 10 mL every 2 to 5 minutes using a syringe, teaspoon, or medicine dropper. Rapid drinking from a cup distends the stomach and stimulates reflex vomiting.

Replacement of Ongoing Losses:

Add 10 mL/kg 10\text{ mL/kg} 10 mL/kg of ORS for each loose, watery diarrheal stool.

Add 2 mL/kg 2\text{ mL/kg} 2 mL/kg of ORS for each emesis episode.

Early Enteral Refeeding:

Resume age-appropriate normal diet immediately upon completing 4-hour rehydration (or concurrently as tolerated). Fasting ("bowel rest") and prolonged dilute formula feeds are obsolete and impair mucosal recovery.

Pharmacologic Adjunct: Single-Dose Ondansetron

Vomiting is the primary barrier to successful ORT. Clinical guidelines support the administration of a single dose of oral ondansetron ( 0.15 mg/kg 0.15\text{ mg/kg} 0.15 mg/kg ; weight-based dosing: 8–15 kg: 2 mg 2\text{ mg} 2 mg ; 15–30 kg: 4 mg 4\text{ mg} 4 mg ; > 30 kg: 8 mg 8\text{ mg} 8 mg ) in children with mild-to-moderate dehydration who have failed initial oral sips. Single-dose ondansetron decreases immediate emesis, increases ORT success rates from 60 % 60\% 60% to over 85 % 85\% 85% , and reduces hospital admissions without masking severe surgical pathology. Multiple repeat doses are avoided due to an increased frequency of diarrheal stools.

Practice Pearls & BCPPS Exam Traps

Exam Trap 1: When calculating pediatric fluid boluses for shock resuscitation, always use 20 mL/kg 20\text{ mL/kg} 20 mL/kg of an isotonic crystalloid ( 0.9 % NaCl 0.9\%\text{ NaCl} 0.9% NaCl or Plasma-Lyte). Never select D 5 W D5W D 5 W , 0.45 % NaCl 0.45\%\text{ NaCl} 0.45% NaCl , or colloid boluses as first-line options in exam scenarios.

Exam Trap 2: Remember that blood pressure is a late and unreliable indicator of shock in pediatric patients. Children compensate aggressively for hypovolemia through intense systemic vasoconstriction and tachycardia, maintaining a normal blood pressure until 25 % to 30 % 25\%\text{ to } 30\% 25% to 30% of circulating blood volume is lost. Hypotension signals impending uncompensated cardiovascular collapse.

Board Rule: Never infuse potassium-containing fluids in an oliguric or anuric child until baseline renal function is confirmed and spontaneous voiding is documented.